Federated Hermes, Inc. Macrogenics Inc Transaction History

Federated Hermes, Inc.

  • $43.9 Billion
  • Q1 2025

A detailed history of Federated Hermes, Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 7,091 shares of MGNX stock, worth $12,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,091
Holding current value
$12,338
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
BUY
$1.26 - $3.49 $8,934 - $24,747
7,091 New
7,091 $9,000
Q2 2024

Aug 08, 2024
SELL
$3.31 - $18.51 $507,201 - $2.84 Million
-153,233 Reduced 33.77%
300,499 $1.28 Million
Q1 2024

May 14, 2024
SELL
$9.77 - $21.47 $3.42 Million - $7.51 Million
-349,643 Reduced 43.52%
453,732 $6.68 Million
Q4 2023

Jan 31, 2024
SELL
$4.48 - $10.11 $567,620 - $1.28 Million
-126,701 Reduced 13.62%
803,375 $7.73 Million
Q3 2023

Nov 13, 2023
SELL
$4.48 - $6.19 $49,665 - $68,622
-11,086 Reduced 1.18%
930,076 $4.33 Million
Q2 2023

Aug 14, 2023
SELL
$4.62 - $7.54 $68,052 - $111,064
-14,730 Reduced 1.54%
941,162 $5.04 Million
Q1 2023

May 08, 2023
SELL
$4.82 - $7.24 $193,233 - $290,251
-40,090 Reduced 4.03%
955,892 $6.85 Million
Q4 2022

Feb 13, 2023
SELL
$3.34 - $6.98 $1.38 Million - $2.89 Million
-414,617 Reduced 29.39%
995,982 $6.68 Million
Q3 2022

Nov 14, 2022
BUY
$3.01 - $5.22 $912,189 - $1.58 Million
303,053 Added 27.36%
1,410,599 $4.88 Million
Q2 2022

Aug 15, 2022
BUY
$2.25 - $9.99 $1.84 Million - $8.16 Million
817,088 Added 281.31%
1,107,546 $3.27 Million
Q1 2022

May 13, 2022
BUY
$8.12 - $16.9 $2.36 Million - $4.91 Million
290,458 New
290,458 $2.56 Million
Q2 2021

Aug 16, 2021
SELL
$20.49 - $35.63 $19,731 - $34,311
-963 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$18.99 - $33.2 $10,083 - $17,629
531 Added 122.92%
963 $31,000
Q4 2020

Feb 12, 2021
SELL
$19.41 - $26.0 $152,057 - $203,684
-7,834 Reduced 94.77%
432 $10,000
Q3 2020

Nov 12, 2020
BUY
$24.69 - $31.6 $101,722 - $130,192
4,120 Added 99.37%
8,266 $209,000
Q2 2020

Aug 13, 2020
SELL
$5.2 - $29.12 $64,084 - $358,874
-12,324 Reduced 74.83%
4,146 $116,000
Q1 2020

May 13, 2020
SELL
$4.28 - $12.11 $8,512 - $24,086
-1,989 Reduced 10.78%
16,470 $96,000
Q4 2019

Feb 14, 2020
SELL
$7.95 - $12.27 $7.51 Million - $11.6 Million
-944,383 Reduced 98.08%
18,459 $201,000
Q3 2019

Nov 14, 2019
BUY
$12.44 - $17.48 $1.41 Million - $1.98 Million
113,035 Added 13.3%
962,842 $12.3 Million
Q2 2019

Aug 14, 2019
SELL
$14.51 - $19.71 $3.64 Million - $4.94 Million
-250,881 Reduced 22.79%
849,807 $14.4 Million
Q1 2019

May 10, 2019
BUY
$11.11 - $25.6 $12.2 Million - $28.2 Million
1,100,155 Added 206408.06%
1,100,688 $19.8 Million
Q4 2018

Feb 13, 2019
SELL
$11.75 - $21.42 $669 - $1,220
-57 Reduced 9.66%
533 $6,000
Q3 2018

Nov 13, 2018
SELL
$19.26 - $23.46 $1,810 - $2,205
-94 Reduced 13.74%
590 $13,000
Q2 2018

Aug 10, 2018
SELL
$19.78 - $24.67 $61,100 - $76,205
-3,089 Reduced 81.87%
684 $14,000
Q1 2018

May 09, 2018
BUY
$18.89 - $32.46 $56,575 - $97,217
2,995 Added 384.96%
3,773 $95,000
Q4 2017

Feb 14, 2018
BUY
$16.19 - $20.3 $3,254 - $4,080
201 Added 34.84%
778 $0
Q3 2017

Nov 13, 2017
BUY
$15.52 - $18.94 $8,955 - $10,928
577
577 $11,000

Others Institutions Holding MGNX

# of Institutions
133
Shares Held
54M
Call Options Held
45.1K
Put Options Held
143K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $107M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email